image
Healthcare - Medical - Healthcare Information Services - NASDAQ - US
$ 1.3
0.775 %
$ 44 M
Market Cap
-1.76
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one BEAT stock under the worst case scenario is HIDDEN Compared to the current market price of 1.3 USD, HeartBeam, Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one BEAT stock under the base case scenario is HIDDEN Compared to the current market price of 1.3 USD, HeartBeam, Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one BEAT stock under the best case scenario is HIDDEN Compared to the current market price of 1.3 USD, HeartBeam, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart BEAT

image
$2.6$2.6$2.4$2.4$2.2$2.2$2.0$2.0$1.8$1.8$1.6$1.6$1.4$1.4$1.2$1.220252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25Jul '25Jul '25
FINANCIALS
0 REVENUE
0.00%
-19.9 M OPERATING INCOME
-29.86%
-19.4 M NET INCOME
-32.85%
-14.5 M OPERATING CASH FLOW
-19.66%
-201 K INVESTING CASH FLOW
21.48%
866 K FINANCING CASH FLOW
-96.54%
0 REVENUE
0.00%
-5.5 M OPERATING INCOME
-11.33%
-5.48 M NET INCOME
-11.76%
-4.48 M OPERATING CASH FLOW
-7.83%
-3.76 M INVESTING CASH FLOW
0.00%
10.2 M FINANCING CASH FLOW
1246.91%
Balance Sheet HeartBeam, Inc.
image
Current Assets 2.77 M
Cash & Short-Term Investments 2.38 M
Receivables 0
Other Current Assets 393 K
Non-Current Assets 506 K
Long-Term Investments 0
PP&E 450 K
Other Non-Current Assets 56 K
72.56 %12.00 %13.74 %Total Assets$3.3m
Current Liabilities 1.62 M
Accounts Payable 531 K
Short-Term Debt 0
Other Current Liabilities 1.09 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0
32.74 %67.26 %Total Liabilities$1.6m
EFFICIENCY
Earnings Waterfall HeartBeam, Inc.
image
Revenue 0
Cost Of Revenue 7 K
Gross Profit 0
Operating Expenses 19.9 M
Operating Income -19.9 M
Other Expenses -439 K
Net Income -19.4 M
00(2m)(2m)(4m)(4m)(6m)(6m)(8m)(8m)(10m)(10m)(12m)(12m)(14m)(14m)(16m)(16m)(18m)(18m)(20m)(20m)0(7k)0(20m)(20m)439k(19m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
0.00% GROSS MARGIN
0.00%
0.00% OPERATING MARGIN
0.00%
0.00% NET MARGIN
0.00%
-1175.82% ROE
-1175.82%
-593.65% ROA
-593.65%
-1202.36% ROIC
-1202.36%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis HeartBeam, Inc.
image
50m50m40m40m30m30m20m20m10m10m00(10m)(10m)(20m)(20m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -19.4 M
Depreciation & Amortization 7 K
Capital Expenditures -201 K
Stock-Based Compensation 4.3 M
Change in Working Capital 671 K
Others 243 K
Free Cash Flow -14.7 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets HeartBeam, Inc.
image
BEAT has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 6
6. Ownership
Insider Ownership HeartBeam, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
28 K USD 1
Bought
0 USD 0
0-3 MONTHS
80 K USD 2
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025 SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025. businesswire.com - 2 weeks ago
HeartBeam, Inc. (BEAT) Q1 2025 Earnings Call Transcript HeartBeam, Inc. (NASDAQ:BEAT ) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Rob Eno - CEO Tim Cruickshank - CFO Larry Holub - IR, MZ Group Conference Call Participants Bill Sutherland - The Benchmark Company Leo Carpio - Joseph Gunnar Operator Greetings and welcome to the HeartBeam First Quarter 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode. seekingalpha.com - 1 month ago
HeartBeam Reports First Quarter 2025 Results SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports First Quarter 2025 Results. businesswire.com - 1 month ago
HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio. businesswire.com - 2 months ago
HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth. businesswire.com - 2 months ago
HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time. businesswire.com - 2 months ago
HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology. businesswire.com - 2 months ago
HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation SANTA CLARA, Calif. & NEW YORK--(BUSINESS WIRE)--HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation. businesswire.com - 2 months ago
HeartBeam, Inc. (BEAT) Q4 2024 Earnings Call Transcript HeartBeam, Inc. (NASDAQ:BEAT ) Q4 2024 Results Conference Call March 13, 2025 4:30 PM ET Company Participants Rob Eno - Chief Executive Officer Tim Cruickshank - Chief Financial Officer Operator Greetings, and welcome to the HeartBeam Fourth Quarter and Full Year 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. seekingalpha.com - 3 months ago
HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025 SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 17-21, 2025. businesswire.com - 4 months ago
HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock. businesswire.com - 4 months ago
HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock. businesswire.com - 4 months ago
8. Profile Summary

HeartBeam, Inc. BEAT

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 44 M
Dividend Yield 0.00%
Description HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
Contact 2118 Walsh Avenue, Santa Clara, CA, 95050 https://www.heartbeam.com
IPO Date Nov. 11, 2021
Employees 21
Officers Mr. Timothy Cruickshank Chief Financial Officer Dr. Lance Myers Ph.D. Chief Artificial Intelligence Scientist Mr. Kenneth Persen Chief Technology Officer Dr. Branislav Vajdic Ph.D. Founder, President & Director Mr. Robert P. Eno Chief Executive Officer, Chief Business Officer & Director Dr. Peter J. Fitzgerald FACC, M.D., Ph.D. Member of Scientific Advisory Board & Chief Medical Officer Ms. Richa Gujarati Senior Vice President of Product Mr. Richard M. Ferrari Executive Chairman